Stephen F. Betz - Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
CRNX on Nasdaq
All Insider Reports
All Insider Reports

Stephen F. Betz - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Stephen F. Betz for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 117,713 $224,831 $1.91 26 Dec 2025 Direct
Stock Option (Right to Buy) 90,514 26 Dec 2025 Direct Common Stock

Transactions reported by Stephen F. Betz for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.